MedTrace Logo

The Causes and Interpretation of Low-level Resistance in Staphylococcus Aureus

NCT01127516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2014-07-09

No results posted yet for this study

Summary

The hypothesis of this investigation is that rate of isolation of resistant nosocomial pathogens can be explained by a combination of measures that include, among other things, antimicrobial drug use, infection control efforts, patient mix and antimicrobial stewardship efforts. The short term goal of this investigation is to improve our understanding of the relationships between antimicrobial stewardship program efforts (and actual antimicrobial drug use), and infection control efforts to the incidence rates of MSSA, MRSA, h-VISA and SA-MICcreep. The long term goal of this investigation is to design interventions that will improve antimicrobial drug use and decrease cross-transmission of resistant bacteria, resulting in a decrease in the rates of infection caused resistant hospital organisms.

Conditions

  • Staphylococcus Aureus

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Virginia Commonwealth University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01127516 on ClinicalTrials.gov